Companion Diagnostics Market Size, Share & Industry Analysis, By Technology (Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization, Next Generation Gene Sequencing, and Others), By Indication (Cancer, Neurological Diseases, Infectious Diseases, and Others), By End-user (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI107097

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Periods	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR 12.86% from 2026-2034
Unit	Value (USD billion)
Segmentation	By Technology Polymerase Chain Reaction Immunohistochemistry In-situ Hybridization Next Generation Gene Sequencing Others
	By Indication Cancer Neurological Diseases Infectious Diseases Others
	By End-user Pharmaceutical & Biopharmaceutical Companies Reference Laboratories Contract Research Organizations (CROs)
	By Geography North America (By Technology, By Indication, By End-user, By Country) U.S. Canada Europe (By Technology, By Indication, By End-user, By Country/Sub-Region) Germany U.K. France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Technology, By Indication, By End-user, By Country/Sub-Region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Technology, By Indication, By End-user, By Country/Sub-Region) Brazil Mexico Rest of Latin America Middle East & Africa (By Technology, By Indication, By End-user, By Country/Sub-Region) GCC South Africa Rest of Middle East & Africa